<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01900964</url>
  </required_header>
  <id_info>
    <org_study_id>12.0455</org_study_id>
    <nct_id>NCT01900964</nct_id>
  </id_info>
  <brief_title>Ridge Preservation Comparing a PTFE Nonresorbable Membrane to a Collagen Membrane</brief_title>
  <official_title>Ridge Preservation Comparing the Clinical and Histologic Healing of a PTFE Non-resorbable vs. a Collagen Membrane With an Intrasocket Mineralized Cancellous Allograft Plus a Facial Overlay Bovine Xenograft.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A non-resorbable PTFE (teflon) membrane will be compared to a resorbable collagen membrane&#xD;
      when used for a post-extraction ridge preservation procedure to prevent the bone loss that&#xD;
      typically occurs. The hypothesis is that there will be no difference in the clinical and&#xD;
      histologic results between the two membranes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patient Selection 30 patients will be selected that meet the following criteria:&#xD;
&#xD;
      Inclusion Criteria&#xD;
&#xD;
        1. Have one non-molar tooth requiring extraction that will be replaced by a dental implant.&#xD;
           The site must be bordered by at least one tooth.&#xD;
&#xD;
        2. Healthy male or female who is at least 18 years old.&#xD;
&#xD;
        3. Patients must sign an informed consent approved by the University of Louisville Human&#xD;
           Studies Committee.&#xD;
&#xD;
      Exclusion Criteria&#xD;
&#xD;
        1. Patients with debilitating systemic diseases, or diseases that have a clinically&#xD;
           significant effect on the periodontium.&#xD;
&#xD;
        2. Presence or history of osteonecrosis of jaws.&#xD;
&#xD;
        3. Patients who are currently taking IV bisphosphonates or who had IV treatment with&#xD;
           bisphosphonates irrespective of duration.&#xD;
&#xD;
        4. Patients who have been treated with oral bisphosphonates for more than three years.&#xD;
&#xD;
        5. Patients with an allergy to any material or medication used in the study.&#xD;
&#xD;
        6. Patients who need prophylactic antibiotics.&#xD;
&#xD;
        7. Previous head and neck radiation therapy.&#xD;
&#xD;
        8. Chemotherapy in the previous 12 months.&#xD;
&#xD;
        9. Patients on long term NSAID or steroid therapy.&#xD;
&#xD;
       10. Pregnant patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Crestal ridge width</measure>
    <time_frame>Time 4 months</time_frame>
    <description>The crestal ridge width will be measured with a digital caliper at the baseline exam and at the 4 month examination.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent vital bone</measure>
    <time_frame>Time 4 months</time_frame>
    <description>A trephine core will be taken at 4 months immediately prior to implant placement from the implant osteotomy site.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Clinical Efficacy</condition>
  <arm_group>
    <arm_group_label>PTFE membrane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A non-resorbable PTFE (polytetrafluoroethylene) membrane will be used as a positive control treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A resorbable collagen membrane will be used in the test group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PTFE membrane</intervention_name>
    <description>The non-resorbable PTFE barrier membrane will be surgically placed in conjunction with a ridge preservation procedure.</description>
    <arm_group_label>PTFE membrane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Collagen membrane</intervention_name>
    <description>A resorbable collagen membrane is surgically placed in conjunction with a ridge preservation procedure.</description>
    <arm_group_label>Collagen membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Have one non-molar tooth requiring extraction that will be replaced by a dental&#xD;
             implant. The site must be bordered by at least one tooth.&#xD;
&#xD;
          2. Healthy male or female who is at least 18 years old.&#xD;
&#xD;
          3. Patients must sign an informed consent approved by the University of Louisville Human&#xD;
             Studies Committee.&#xD;
&#xD;
             -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with debilitating systemic diseases, or diseases that have a clinically&#xD;
             significant effect on the periodontium.&#xD;
&#xD;
          2. Presence or history of osteonecrosis of jaws.&#xD;
&#xD;
          3. Patients who are currently taking IV bisphosphonates or who had IV treatment with&#xD;
             bisphosphonates irrespective of duration.&#xD;
&#xD;
          4. Patients who have been treated with oral bisphosphonates for more than three years.&#xD;
&#xD;
          5. Patients with an allergy to any material or medication used in the study.&#xD;
&#xD;
          6. Patients who need prophylactic antibiotics.&#xD;
&#xD;
          7. Previous head and neck radiation therapy.&#xD;
&#xD;
          8. Chemotherapy in the previous 12 months.&#xD;
&#xD;
          9. Patients on long term NSAID (nonsteroidal anti-inflammatory drug) or steroid therapy.&#xD;
&#xD;
         10. Pregnant patients. -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry Greenwell, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Graduate Periodontics Clinic, University of Louisville</name>
      <address>
        <city>Louisvile</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <study_first_submitted>July 10, 2013</study_first_submitted>
  <study_first_submitted_qc>July 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2013</study_first_posted>
  <last_update_submitted>December 6, 2016</last_update_submitted>
  <last_update_submitted_qc>December 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Henry Greenwell</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Regeneration</keyword>
  <keyword>Bone regeneration</keyword>
  <keyword>Grafting, Bone</keyword>
  <keyword>Allograft</keyword>
  <keyword>Xenograft</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

